by Strados Labs | May 3, 2022 | Press Releases
Philadelphia, PA May 3, 2022 — Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of worsening respiratory diseases, today announced it has received...
by Strados Labs | Mar 10, 2022 | Press Releases
Funding will help Strados advance the power of its smart sensors to provide early detection and predictions of infectious respiratory diseases Philadelphia, PA, March 10, 2020 — Strados Labs, a medical technology company harnessing the power of smart sensors, machine...
by Strados Labs | Jan 4, 2022 | Press Releases
Funding to fuel next key milestones as company continues to target asthma, COPD and infectious respiratory diseases in 2022 Philadelphia, PA January 5, 2022 — Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and...
by Strados Labs | Dec 16, 2021 | Press Releases
Strados Labs harnesses the power of smart sensors and machine learning to aid in early detection and predictions of worsening respiratory diseases for enhanced patient care Philadelphia, PA, December 16, 2021 – Strados Labs, a medical technology company harnessing...
by Strados Labs | Nov 18, 2021 | Press Releases
CE Mark expands the company’s reach to support customers on a global scale Philadelphia, PA, November 18, 2021 – Strados Labs, a medical technology company harnessing the power of smart sensors to aid in early detection and predictions of worsening diseases for...
by Strados Labs | Dec 22, 2020 | Press Releases
Philadelphia, PA December 22, 2020 — Strados Labs, a health technology developer of remote respiratory devices and software, today announced it has received FDA Class II 510(k) clearance for its first product, RESP™, a system for measuring, recording and analyzing...
